Clinical evaluation of a first trimester pregnancy algorithm predicting the risk of small for gestational age neonates.
PAPP-A
first trimester screening
mean arterial pressure
small for gestational age
uterine artery Doppler
Journal
The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
10
09
2018
accepted:
20
12
2018
pubmed:
27
1
2019
medline:
5
8
2020
entrez:
26
1
2019
Statut:
ppublish
Résumé
The Fetal Medicine Foundation developed a multiple logistic regression algorithm for risk prediction of delivering a small for gestational age neonate. To validate this algorithm in an Australian population. At the combined first trimester screen participants' medical histories, demographic data, mean arterial pressure, uterine artery pulsatility index and pregnancy-associated plasma protein-A were assessed. After delivery, risk of delivering a small for gestational age neonate at <37 or ≥37 weeks gestation was retrospectively calculated using the Fetal Medicine Foundation algorithm. Three thousand and eight women underwent prediction of risk for delivering a small for gestational age neonate. The algorithm detected 15.0% (95% CI: 3.2-37.9) of small for gestational age neonates delivered <37 weeks gestation at a fixed 10% false positive rate (or 35.0% (95% CI: 15.4-59.2) at a fixed 20% false positive rate). It detected 23.4% (95% CI: 16.1-30.7) of small for gestational age neonates delivered ≥37 weeks gestation at a fixed 10% false positive rate (or 39.1% (95% CI: 30.7-47.5) at a fixed 20% false positive rate). The algorithm performed significantly better than individual parameters (P < 0.05). The area under the receiver operating characteristic curve was 0.68 (95% CI: 0.56-0.80) and 0.70 (95% CI: 0.65-0.74) for small for gestational age neonates at <37 and ≥37 weeks gestation, respectively. The Fetal Medicine Foundation algorithm for first trimester prediction of small for gestational age neonates does not perform as well in an Australian population as in the original United Kingdom cohort. However, it performs significantly better than any individual test parameter in both preterm and term neonates. Incorporation of further variables may help improve screening efficacy.
Sections du résumé
BACKGROUND
The Fetal Medicine Foundation developed a multiple logistic regression algorithm for risk prediction of delivering a small for gestational age neonate.
AIM
To validate this algorithm in an Australian population.
METHODS
At the combined first trimester screen participants' medical histories, demographic data, mean arterial pressure, uterine artery pulsatility index and pregnancy-associated plasma protein-A were assessed. After delivery, risk of delivering a small for gestational age neonate at <37 or ≥37 weeks gestation was retrospectively calculated using the Fetal Medicine Foundation algorithm.
RESULTS
Three thousand and eight women underwent prediction of risk for delivering a small for gestational age neonate. The algorithm detected 15.0% (95% CI: 3.2-37.9) of small for gestational age neonates delivered <37 weeks gestation at a fixed 10% false positive rate (or 35.0% (95% CI: 15.4-59.2) at a fixed 20% false positive rate). It detected 23.4% (95% CI: 16.1-30.7) of small for gestational age neonates delivered ≥37 weeks gestation at a fixed 10% false positive rate (or 39.1% (95% CI: 30.7-47.5) at a fixed 20% false positive rate). The algorithm performed significantly better than individual parameters (P < 0.05). The area under the receiver operating characteristic curve was 0.68 (95% CI: 0.56-0.80) and 0.70 (95% CI: 0.65-0.74) for small for gestational age neonates at <37 and ≥37 weeks gestation, respectively.
CONCLUSIONS
The Fetal Medicine Foundation algorithm for first trimester prediction of small for gestational age neonates does not perform as well in an Australian population as in the original United Kingdom cohort. However, it performs significantly better than any individual test parameter in both preterm and term neonates. Incorporation of further variables may help improve screening efficacy.
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
670-676Informations de copyright
© 2019 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Références
Lees C, Marlow N, Arabin B et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol 2013; 42: 400-408.
Flenady V, Koopmans L, Middleton P et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 2011; 377(9774): 1331-1340.
Badawi N, Kurinczuk JJ, Keogh JM et al. Antepartum risk factors for newborn encephalopathy: The Western Australian case-control study. BMJ 1998; 317(7172): 1549-1553.
Skilton MR, Evans N, Griffiths KA et al. Aortic wall thickness in newborns with intrauterine growth restriction. Lancet 2005; 365(9469): 1484-1486.
Barker DJ, Osmond C, Golding J et al. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989; 298(6673): 564-567.
Chow SSW, Le Marsney R, Hossain S et al. Report of the Australian and New Zealand Neonatal Network. Sydney: Australia and New Zealand Neonatal Network, 2013.
Marconi AM, Paolini CL. Nutrient transport across the intrauterine growth-restricted placenta. Semin Perinatol 2008; 32(3): 178-181.
Hernandez-Andrade E, Serralde JA, Cruz-Martinez R. Can anomalies of fetal brain circulation be useful in the management of growth restricted fetuses? Prenat Diagn 2012; 32: 103-112.
Li CCY, Maloney CA, Cropley JE, Suter CM. Epigenetic programming by maternal nutritions: shaping future generations. Epigenomics 2010; 2(4): 539-549.
Mifsud W, Sebire NJ. Placental pathology in early-onset and late-onset fetal growth restriction. Fetal Diagn Ther 2014; 36: 117-128.
Crovetto F, Triunfo S, Crispi F et al. First-trimester screening with specific algorithms for early- and late-onset fetal growth restriction. Ultrasound Obstet Gynecol 2016; 48: 340-348.
Leitich H, Egarter C, Husslein P et al. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 1997; 104: 450-459.
Roberge S, Nicolaides K, Demers S et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol 2017; 216: 110-120.
Gaccioli F, Aye ILM, Sovio U et al. Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers. Am J Obstet Gynecol 2018; 218(2S): S725-S737.
Crovetto F, Triunfo S, Crispi F et al. Differential performance of first trimester screening in predicting small-for-gestational-age neonate or fetal growth restriction. Ultrasound Obstet Gynecol 2017; 49: 349-356.
Poon CY, Syngelaki A, Akolekar R et al. Combined screening for preeclampsia and small for gestational age at 11-13 Weeks. Fetal Diagn Ther 2013; 33: 16-27.
Poon LC, Zymeri NA, Zamprakou A et al. Protocol for measurement of mean arterial pressure at 11-13 weeks’ gestation. Fetal Diagn Ther 2012; 31: 42-48.
Park FJ, Leung CH, Poon LC et al. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Aust N Z J Obstet Gynaecol 2013; 53(6): 532-539.
Joseph FA, Hyett JA, McGeechan K et al. A new approach to developing birth weight reference charts: a retrospective observational study. Fetal Diagn Ther 2018; 43: 148-155.
Ong CY, Liao AW, Spencer K et al. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000; 107(10): 1265-1270.
Spencer K, Cowans NJ, Avgidou K et al. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2008; 31: 15-19.
Zhong Y, Zhu F, Ding Y. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. BMC Pregnancy Childbirth 2015; 15: 191.
Wright A, Wright D, Ispas CA et al. Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 2015; 45: 698-706.
Block-Abraham DM, Adamovich D, Turan OM et al. Maternal blood pressures during pregnancy and the risk of delivering a small-for-gestational-age neonate. Hypertens Pregnancy 2016; 35: 350-360.
Plasencia W, Maiz N, Bonino S et al. Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007; 30(5): 742-749.
Unterscheider J, Daly S, Geary MP et al. Optimizing the definition of intrauterine growth restriction: the multicentre prospective PORTO Study. Am J Obstet Gynecol 2013; 208(4): 290.e1-6.
Mlynarczyk M, Chauhan SP, Baydoun HA et al. The clinical significance of an estimated fetal weight below the 10th percentile: a comparison of outcomes of <5th vs 5-9th percentile. Am J Obstet Gynecol 2017; 217(2): 198.e1-198.e11.
Velauthar L, Plana MN, Kalidindi M et al. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55 974 women. Ultrasound Obstet Gynecol 2014; 43: 500-507.
Karagiannis G, Akolekar R, Sarquis R et al. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks. Fetal Diagn Ther 2011; 29: 148-154.
Mosimann B, Pfiffner C, Amylidi-Mohr S et al. First trimester combined screening for preeclampsia and small for gestational age - a single centre experience and validation of the FMF screening algorithm. Swiss Med Wkly 2017; 147: w14498.